Long‐term results of a phase II trial with frontline concurrent chemoradiotherapy followed by consolidation chemotherapy for localized nasal natural killer/T‐cell lymphoma

Publisher： John Wiley & Sons Inc

E-ISSN： 1600-0609|94|2|130-137

ISSN： 0902-4441

Source： EUROPEAN JOURNAL OF HAEMATOLOGY, Vol.94, Iss.2, 2015-02, pp. : 130-137

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Extranodal Natural Killer/T-Cell Lymphoma of the Nasal Type with Skin Metastases

By  

Case Reports in Oncology, Vol. 9, Iss. 1, 2016-01 ,pp. : 1-5

Karger

Access to resources Recommend Favorite

Nasal endoscopic evaluation and its impact on survival in patients with stage I/II extranodal natural killer/T‐cell lymphoma, nasal type

By  

INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY, Vol. 5, Iss. 10, 2015-10 ,pp. : 960-966

John Wiley & Sons Inc

Access to resources Recommend Favorite

Concurrent Chemoradiotherapy with a Novel Fluoropyrimidine, S-1, and Cisplatin for Locally Advanced Esophageal Cancer: Long-Term Results of a Phase II Trial

By  

Oncology, Vol. 84, Iss. 6, 2013-05 ,pp. : 342-349

Karger

Access to resources Recommend Favorite

Extranodal natural killer/T‐cell lymphoma, nasal type, presenting with altered CD56 expression: A case report

By  

THE JOURNAL OF DERMATOLOGY, Vol. 385-2407, Iss. 10, 2015-10 ,pp. : 1022-1023

John Wiley & Sons Inc

Access to resources Recommend Favorite

Extranodal natural killer/T‐cell lymphoma, nasal type, presenting with altered CD56 expression: A case report

By  

THE JOURNAL OF DERMATOLOGY, Vol. 42, Iss. 10, 2015-10 ,pp. : 1022-1023

John Wiley & Sons Inc

Access to resources Recommend Favorite